Theriva Biologics, Inc. (TOVX) — Total Assets

Annual figures by fiscal year, from SEC filings.

2010: $4.11M2011: $7.48M2012: $13.42M2013: $16.26M2014: $19.14M2015: $30.84M2016: $22.50M2017: $18.84M2018: $30.14M2019: $17.23M2020: $8.41M2021: $70.36M2022: $71.86M2023: $55.22M2024: $35.35M2025: $38.24M$38.24M
2010Total Assets (USD)2025
Fiscal YearTotal AssetsChange YoY
2025$38.24M+8.2%
2024$35.35M-36.0%
2023$55.22M-23.2%
2022$71.86M+2.1%
2021$70.36M+736.7%
2020$8.41M-51.2%
2019$17.23M-42.8%
2018$30.14M+60.0%
2017$18.84M-16.3%
2016$22.50M-27.1%
2015$30.84M+61.1%
2014$19.14M+17.8%
2013$16.26M+21.1%
2012$13.42M+79.5%
2011$7.48M+81.9%
2010$4.11M